![]() |
Study Once More Underpins The Clinical Value Of FDA-Cleared Breast Cancer Recurrence
Agendia, a world leader in molecular cancer diagnostics, announced recently that together with several groups of scientific collaborators it has identified a major role for TSPYL5, one of its MammaPrint breast cancer prognosis genes, in the genesis of breast cancer...
More... |
| All times are GMT -7. The time now is 08:00 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021